Clinical Cardiology 910 - Clinical Cardiology Alert - Oct 01, 2005

Target Audience:

This activity is intended for the cardiologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Michael H. Crawford, MD
Professor of Medicine
Chief of Clinical Cardiology
University of California
San Francisco

Editorial Board Members
John P. DiMarco, MD, PhD
Professor of Medicine
Division of Cardiology
University of Virginia

Jonathan Abrams, MD
Professor of Medicine
Division of Cardiology
University of New Mexico


  • Interventional vs Conservative Strategy for Non-ST Elevation Acute Coronary Syndrome
  • Dual Therapy for Acute STEMI: Has The Time Arrived?
  • Reversal of Cardiomyopathy in Patients With Repetitive Ventricular Ectopy
  • Left Atrial Size in Competitive Athletes
  • QRS Duration Does Not Predict Occurrence of VT in Patients with ICDs
  • Risk of Noncardiac Surgery with Aortic Stenosis


  • to present the latest information regarding diagnosis and treatment of cardiac disease
  • to discuss the pros and cons of these interventions, as well as possible complications
  • to discuss the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • to present current data regarding outpatient care of cardiac patients

Financial Disclosure:

Clinical Cardiology Alert’s physician editor, Michael H. Crawford, MD, is on the speaker’s bureau for Pfizer. Jonathan Abrams, MD serves on the speaker's bureau for Merck, Pfizer, and Parke-Davis. John P. DiMarco, MD, PhD is a consultant for Novartis, and does research for Medtronic and Guidant.

Copyright 2005 AHC Media. All rights reserved.